Verifying Clearance...
FDA Vaccine Panel Set to Review Moderna's mRNA Flu Shot
The FDA's vaccine advisory panel is preparing to evaluate Moderna's candidate for an mRNA flu vaccine, with a focus on its potential approval for the general public.
This story is using an image pulled from the original reporting.
READ NEXT
Recommended Intelligence
Looking for the best next stories...
No comments yet. Start the conversation.